Company intelligence / Profile preview

GY Highland Biotech

Watchung, New Jersey, United States of America

Ownership: Private
Employees: ~25
Development stage: Commercial

Overview

GY Highland Biotech has developed and commercialized the FRD™ staining solution, a rapid, real-time diagnostic tool for detecting precancerous and cancerous lesions on the cervix with high sensitivity (~85% for CIN2+). The technology is also being expanded to other cancers. The company focuses on providing accurate, affordable solutions primarily in women’s health and oncology diagnostics.

Therapeutic areas: Oncology
Modalities: Diagnostic testImmunochemistry testingMolecular diagnostic kit
Industry: Protein Biomarker Diagnostics

Partnerships

none publicly disclosed; close relationship with Shaanxi Gaoyuan In Vitro Diagnostic Reagents Co., Ltd.

Beyond the preview

Go deeper on GY Highland Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GY Highland Biotech.

Explore the full profile